🔎 Trials Near Me

Home › Glioblastoma › Minnesota

Pag-aaral pangklinika para sa Glioblastoma sa Minnesota

19 pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa mga site sa Minnesota.

Mga Lungsod sa Minnesota

Opisyal na teksto ng pag-aaral (English)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Atrium Health Levine Cancer Institute, Minneapolis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07326566

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

  • Mayo Clinic in Rochester, Rochester
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

  • Allina Health Systems/Abbott Northwestern Hospital, Minneapolis
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT03970447

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

  • Mayo Clinic in Rochester, Rochester
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07301268

Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma

  • Mayo Clinic in Rochester, Rochester
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07708961

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Mayo Clinic Cancer Center, Rochester
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06810544

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Mayo Clinic - Rochester, Rochester
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT05303519

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

  • University of Minnesota Radiation Oncology, Minneapolis
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07831772

Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma

  • Mayo Clinic in Rochester, Rochester
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07076472

Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

  • Mayo Clinic in Rochester, Rochester
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT04047264

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

  • Mayo Clinic in Rochester, Rochester
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07091864

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial

  • Mayo Clinic in Rochester, Rochester
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07074756

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

  • Mayo Clinic, Rochester
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT07225621

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

  • Mayo Clinic in Rochester, Rochester
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT07468136

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

  • Elizabeth C. Neil, MD, Minneapolis
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update May 1, 2026 · NCT07560865

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

  • Mayo Clinic in Rochester, Rochester
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 21, 2026 · NCT05917145

A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients

  • Mayo Clinic Hospital, Rochester
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT07185880

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duluth
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

  • Mayo Clinic, Rochester
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 19, 2024 · NCT06160206

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.